Delivery Order SPE2DB22D1106-SPE2DB24FELY6
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,634.00 firm-fixed-price delivery order is for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in 120-count packages. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.97 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,932.61 firm fixed-price delivery order is for alfuzosin HCL extended-release 10 mg tablets, with an ultimate completion date of October 30, 2024. The award is part of a larger, $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in packages of 90. The contract has a firm fixed price of $4,206.45 and an ultimate completion date of September 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is not a set-aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The contract has a firm fixed-price delivery order type, a ceiling value of $1,542.30, and a completion date of September 17, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
This federal contract award, valued at $4,281.55, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets, a medication used to treat symptoms of an enlarged prostate. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued...
This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.48 delivery order contract is for the supply of Alfuzosin HCL ER 10 mg tablets, and has a period of performance through October 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,024.84 firm fixed price delivery order is for the supply of 10 mg alfuzosin hydrochloride extended-release tablets. Amerisourcebergen Drug Corp holds a larger, single-award indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...